vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 7.4%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 4.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
CTKB vs HSTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $79.7M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 3.0% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 7.4% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $79.7M | ||
| Q3 25 | $52.3M | $76.5M | ||
| Q2 25 | $45.6M | $74.4M | ||
| Q1 25 | $41.5M | $73.5M | ||
| Q4 24 | $57.5M | $74.2M | ||
| Q3 24 | $51.5M | $73.1M | ||
| Q2 24 | $46.6M | $71.6M | ||
| Q1 24 | $44.9M | $72.8M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $6.1M | ||
| Q2 25 | $-5.6M | $5.4M | ||
| Q1 25 | $-11.4M | $4.3M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $5.7M | ||
| Q2 24 | $-10.4M | $4.2M | ||
| Q1 24 | $-6.2M | $5.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 3.0% | ||
| Q3 25 | -17.6% | 9.9% | ||
| Q2 25 | -23.3% | 7.9% | ||
| Q1 25 | -36.1% | 6.0% | ||
| Q4 24 | 5.2% | 6.3% | ||
| Q3 24 | -8.2% | 8.9% | ||
| Q2 24 | -18.3% | 6.2% | ||
| Q1 24 | -23.9% | 7.8% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 8.0% | ||
| Q2 25 | -12.2% | 7.2% | ||
| Q1 25 | -27.5% | 5.9% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 7.8% | ||
| Q2 24 | -22.4% | 5.8% | ||
| Q1 24 | -13.8% | 7.2% |
| Q4 25 | — | $0.09 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | — | $0.18 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | — | $0.19 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $36.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $354.0M |
| Total Assets | $461.5M | $520.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $36.2M | ||
| Q3 25 | $93.3M | $53.5M | ||
| Q2 25 | $75.5M | $52.1M | ||
| Q1 25 | $95.3M | $77.3M | ||
| Q4 24 | $98.7M | $59.5M | ||
| Q3 24 | $162.3M | $57.5M | ||
| Q2 24 | $177.9M | $46.1M | ||
| Q1 24 | $168.8M | $52.4M |
| Q4 25 | $341.7M | $354.0M | ||
| Q3 25 | $378.6M | $349.2M | ||
| Q2 25 | $377.6M | $350.6M | ||
| Q1 25 | $379.6M | $362.8M | ||
| Q4 24 | $395.7M | $359.4M | ||
| Q3 24 | $385.5M | $355.5M | ||
| Q2 24 | $389.1M | $349.2M | ||
| Q1 24 | $392.6M | $344.9M |
| Q4 25 | $461.5M | $520.4M | ||
| Q3 25 | $494.9M | $499.9M | ||
| Q2 25 | $493.3M | $500.1M | ||
| Q1 25 | $482.6M | $524.0M | ||
| Q4 24 | $499.5M | $510.8M | ||
| Q3 24 | $491.2M | $502.8M | ||
| Q2 24 | $483.7M | $499.6M | ||
| Q1 24 | $492.1M | $511.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $13.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $13.0M |
| FCF MarginFCF / Revenue | -2.9% | 16.3% |
| Capex IntensityCapex / Revenue | 1.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $59.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $13.2M | ||
| Q3 25 | $-3.9M | $18.0M | ||
| Q2 25 | $108.0K | $5.0M | ||
| Q1 25 | $-125.0K | $27.1M | ||
| Q4 24 | $2.0M | $11.2M | ||
| Q3 24 | $13.2M | $19.1M | ||
| Q2 24 | $6.2M | $6.5M | ||
| Q1 24 | $4.0M | $20.9M |
| Q4 25 | $-1.8M | $13.0M | ||
| Q3 25 | $-4.6M | $17.9M | ||
| Q2 25 | $-1.5M | $2.7M | ||
| Q1 25 | $-974.0K | $26.0M | ||
| Q4 24 | $1.1M | $11.0M | ||
| Q3 24 | $12.2M | $18.8M | ||
| Q2 24 | $5.2M | $6.3M | ||
| Q1 24 | $3.4M | $20.2M |
| Q4 25 | -2.9% | 16.3% | ||
| Q3 25 | -8.7% | 23.4% | ||
| Q2 25 | -3.2% | 3.6% | ||
| Q1 25 | -2.3% | 35.4% | ||
| Q4 24 | 1.9% | 14.8% | ||
| Q3 24 | 23.7% | 25.8% | ||
| Q2 24 | 11.0% | 8.8% | ||
| Q1 24 | 7.6% | 27.8% |
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 3.1% | ||
| Q1 25 | 2.0% | 1.4% | ||
| Q4 24 | 1.6% | 0.3% | ||
| Q3 24 | 2.0% | 0.4% | ||
| Q2 24 | 2.3% | 0.2% | ||
| Q1 24 | 1.3% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 6.25× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 3.34× | ||
| Q2 24 | — | 1.55× | ||
| Q1 24 | — | 4.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
